KR101578444B1 - Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method - Google Patents

Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method Download PDF

Info

Publication number
KR101578444B1
KR101578444B1 KR1020130076352A KR20130076352A KR101578444B1 KR 101578444 B1 KR101578444 B1 KR 101578444B1 KR 1020130076352 A KR1020130076352 A KR 1020130076352A KR 20130076352 A KR20130076352 A KR 20130076352A KR 101578444 B1 KR101578444 B1 KR 101578444B1
Authority
KR
South Korea
Prior art keywords
foot
mouth disease
virus
recombinant
type
Prior art date
Application number
KR1020130076352A
Other languages
Korean (ko)
Other versions
KR20150003947A (en
Inventor
박종현
이광녕
김수미
이여주
김래형
박정남
고영준
이향심
서민구
탁동섭
김병한
Original Assignee
대한민국
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대한민국 filed Critical 대한민국
Priority to KR1020130076352A priority Critical patent/KR101578444B1/en
Publication of KR20150003947A publication Critical patent/KR20150003947A/en
Application granted granted Critical
Publication of KR101578444B1 publication Critical patent/KR101578444B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

본 발명은 구제역 A형 한국 분리 바이러스(A/KOR/Pocheon/2010)의 전체 유전자가 삽입된 플라스미드를 포함하고, 구제역 A형 아시아 지역형에 대한 방어 면역능을 갖는 재조합 구제역 바이러스 및 그의 제조방법에 관한 것이다.The present invention relates to a recombinant foot-and-mouth disease virus having protective immunity against a foot-and-mouth disease type A Asian region and a method for producing the same, including a plasmid in which a whole gene of foot-and-mouth disease type A isolate Korean isolate virus (A / KOR / Pocheon / 2010) will be.

Description

구제역 A형 한국분리주를 이용한 재조합 구제역 바이러스 및 그의 제조방법{Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method}[0001] The present invention relates to recombinant foot-and-mouth disease virus (hereinafter referred to as " foot-and-mouth disease virus "

본 발명은 구제역 A형 한국분리주를 이용한 재조합 구제역 바이러스 및 그의 제조방법에 관한 것으로, 좀더 상세하게는 구제역 A형 한국 분리 바이러스(A/KOR/Pocheon/2010)의 전체 유전자가 삽입된 플라스미드를 포함하고, 구제역 A형 아시아 지역형에 대한 방어 면역능을 갖는 재조합 구제역 바이러스 및 그의 제조방법에 관한 것이다.The present invention relates to a recombinant foot-and-mouth disease virus using a foot-and-mouth disease type A isolate in Korea, and more particularly, to a method for producing a foot-and-mouth disease virus including a plasmid in which a whole gene of foot-and-mouth disease type A isolate virus (A / KOR / Pocheon / 2010) , A foot-and-mouth disease type A Asian region, and a method for producing the recombinant foot-and-mouth disease virus.

구제역(Foot-and-mouth disease; FMD)은 발굽이 둘로 갈라진 동물에 감염되는 바이러스 수포성 질병으로 빠른 복제와 빠른 전파력이 특징이다. 이 질병은 그 경제적 중요성으로 인하여 세계동물보건기구(OIE)에 의하여 국가간 전파가 가능한 매우 중요한 동물질병으로 분류되어 있으며, 이러한 특성 때문에 축산물의 국가간 교역에 있어 발생유무는 가장 중요한 점검요소로 작용하고 있다. Foot-and-mouth disease (FMD) is a virus-borne disease that infects animals with split hoofs and is characterized by rapid replication and rapid spreading. Due to its economic importance, this disease is classified as a very important animal disease that can be transmitted by the World Animal Health Organization (OIE). Due to these characteristics, the occurrence of livestock products in the international trade is the most important check factor .

상기 구제역 병원체는 단일가닥의 양극성 RNA 바이러스로 피코나비리데(Piconaviridae)과, 아프소바이러스(Aphthovirus)속에 속하며 7개의 다른 혈청형(A, O, C, Asia1, SAT 1, SAT2, SAT3)으로 분류되고 있다.The foot-and-mouth disease pathogen is a single-stranded bipolar RNA virus, which belongs to the genus Piconaviridae and Aphthovirus and has seven different serotypes (A, O, C, Asia, SAT 1, SAT 2 and SAT 3) Being classified.

구제역 바이러스(Foot-and-mouth disease virus) A형 중에서도 ME-SA(중동-남아시아), AFRICA(아프리카), ASIA(아시아)의 3 가지의 지역형이 있다. 이 지역형간에도 변이율이 높아 바이러스 공격에 대한 방어가 되지 않는 경우가 많아 A형 바이러스에 대한 여러 종류의 백신의 개발이 필요한 실정이다. Of the A-type foot-and-mouth disease viruses, there are three regional types: ME-SA (Middle East-South Asia), AFRICA (Africa), and ASIA (Asia). This type of vaccine is required to develop various types of vaccine against A virus because it is not protected against virus attack because the rate of change is high.

A형 구제역은 2010년에 한국에서 처음으로 발생하였다. 이 당시에는 구제역 백신 접종을 실시하지 않았으나, 한국 주변지역에 2009년부터 A형의 구제역이 발생되고 있었다. 그러나 비축되어 있는 구제역 백신주는 세계적으로 널리 사용되는 A22/Iraq/24/64 바이러스 백신주이지만, 우리나라에서 발생된 바이러스와는 항원 연관성이 낮아 그 백신이 접종되더라도 방어 면역성은 비교적 낮을 것으로 추정되었다.A type foot-and-mouth disease occurred in Korea for the first time in 2010. At that time, there was no vaccination against foot-and-mouth disease, but a type-A foot-and-mouth disease was occurring in Korea around 2009. However, the stockpile vaccine strain A22 / Iraq / 24/64 is widely used in the world, but it is presumed that the vaccine immunity will be relatively low even if the vaccine is inoculated because it has low antigenicity with viruses generated in Korea.

2010년 11월 대규모의 구제역 발생이후 처음에는 O형 백신만을 접종하다가 2011년 하반기에 O, A, Asia1형 3가 백신을 접종하기 시작하였고, 그 중 A형은 2010년 1월에 발생한 바이러스와 항원성이 중간 정도로 연관성이 있는 A Malaysia 97 바이러스주가 포함된 백신을 2011년 하반기부터 사용하였다.Since the outbreak of massive foot and mouth disease in November 2010, only the O-type vaccine has been inoculated. In the second half of 2011, vaccines for O, A and Asia type 1 trivalent vaccines have been started. Among them, A vaccine containing the A Malaysia 97 virus strain, which has a moderate correlation with sex, has been in use since the second half of 2011.

한국에서 분리된 바이러스는 아시아 지역형으로서, 유전적으로는 Sea-97 계통(Sea-97 lineage)에 속하는 바이러스이며, 상기 바이러스는 아시아 지역에서 발생하는 바이러스로 현재까지도 아시아 지역에서 발생하고 있어, 상기 바이러스에 대한 백신의 개발이 절실히 요구되고 있는 실정이다. The virus isolated from Korea is an Asian type virus and belongs to the Sea-97 lineage genetically, and the virus is a virus that occurs in Asia and is still present in Asia, The development of a vaccine against such diseases is urgently required.

본 발명자들은 구제역 A형 아시아 지역형 바이러스에 대해 적절하게 방어하기 위하여, 한국에서 분리된 구제역 A형 바이러스(A/KOR/Pocheon/2010)의 유전자 전체 게놈을 플라스미드에 클로닝한 바이러스 벡터를 기초로, 상기 구제역 A형 한국분리주와 항원형이 동일한 새로운 구제역 재조합 바이러스를 제공할 수 있음을 알아내고, 본 발명을 완성하였다.In order to adequately defend against foot-and-mouth disease type A Asian viruses, the inventors of the present invention have developed a vaccine based on a virus vector obtained by cloning a whole genome of a foot-and-mouth disease virus A (A / KOR / Pocheon / 2010) The inventors have found that a new foot-and-mouth disease recombinant virus having the same anti-circular form as the foot-and-mouth disease type A isolate of Korea can be provided.

따라서, 본 발명의 목적은 구제역 A형 아시아 지역형에 대한 방어 면역능을 구비하여 백신 종독주로 유용하게 사용될 수 있는 재조합 구제역 바이러스를 제공하는 것이다.Accordingly, it is an object of the present invention to provide a recombinant foot-and-mouth disease virus which has defense immunity against foot-and-mouth disease type A Asian region type and can be usefully used as a vaccine seedling.

본 발명의 다른 목적은 구제역 A형 아시아 지역형에 대한 방어 면역능을 구비하여 백신 종독주로 유용하게 사용될 수 있는 재조합 구제역 바이러스의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for producing recombinant foot-and-mouth disease virus, which has defense immunity against foot-and-mouth disease type A type Asian region and can be usefully used as a vaccine seedling.

본 발명은 상기와 같은 목적을 달성하기 위하여, 적어도 진뱅크 억세션 넘버 KC588943의 염기서열을 갖는 구제역 A형 한국 분리 바이러스(A/KOR/Pocheon/2010)의 전체 유전자가 삽입된 플라스미드를 포함하고, 구제역 A형 아시아 지역형에 대한 방어 면역능을 갖는 재조합 구제역 바이러스를 제공한다.In order to achieve the above object, the present invention provides a plasmid in which a whole gene of a foot-and-mouth disease type A Korean isolate virus (A / KOR / Pocheon / 2010) having a nucleotide sequence of at least a gene bank number KC588943 is inserted, The present invention provides a recombinant foot-and-mouth disease virus having defense immunity against foot-and-mouth disease type A Asian type.

또한, 본 발명은 (1) 진뱅크 억세션 넘버 KC588943의 염기서열을 갖는 구제역 A형 한국 분리 바이러스의 전체 유전자를 플라스미드에 삽입하는 단계, 및 (2) 상기 (1) 단계에서 얻은 플라스미드를 세포에 주입하여 증식시키는 단계를 포함하는 재조합 구제역 바이러스의 제조방법을 제공한다.The present invention also relates to a method for producing a recombinant virus comprising the steps of: (1) inserting a whole gene of foot-and-mouth disease type A isolate virus having the nucleotide sequence of KC588943 in a plasmid; and (2) introducing the plasmid obtained in the above step And then proliferating the recombinant foot-and-mouth disease virus.

본 발명에 의한 재조합 구제역 바이러스는 동아시아, 중국 또는 대만 등 한국 주변에서 발생하는 구제역 A형 바이러스 아시아 지역형을 효과적으로 방어할 수 있는 구제역 백신을 제공할 수 있다.The recombinant foot-and-mouth disease virus according to the present invention can provide a foot-and-mouth disease vaccine capable of effectively defending the foot-and-mouth disease type A virus type Asian region occurring in Korea, such as East Asia, China or Taiwan.

또한, 본 발명에 의한 재조합 구제역 바이러스는 바이러스 역가가 원래의 바이러스와 크게 차이를 보이지 않으면서, 동아시아, 중국 등 한국 주변에서 발생하는 구제역 A형 바이러스 아시아 지역형을 효과적으로 방어할 수 있는 효과를 얻을 수 있다. In addition, the recombinant foot-and-mouth disease virus according to the present invention can effectively prevent the type of foot-and-mouth disease virus type Asian region occurring in the vicinity of Korea such as East Asia and China while the virus titer does not greatly differ from the original virus have.

도 1은 구제역 A형 한국 분리주를 이용한 재조합 바이러스의 게놈 모식도를 나타낸 것이다.
도 2는 구제역 A형 한국 분리주의 전체 유전자가 삽입된 플라스미드(pA-Kor-Poc)의 모식도를 나타낸 것이다.
도 3은 간이 항원 킷트를 이용하여 본 발명에 의한 재조합 구제역 바이러스에서 발현된 단백질이 구제역 항원 양성 반응을 보임을 나타낸 것이다.
도 4는 구제역 바이러스가 감염된 세포에서의 바이러스 감염세포(형광항체법 검출) 및 세포변성효과를 보여주는 사진이다.
도 5는 본 발명에 의한 재조합 구제역 바이러스가 염소 태아 혀 세포주(ZZ-R), 돼지 신장 세포주(IBRS-2) 및 햄스터 세포주(BHK-21)에서 자라서 바이러스 역가를 형성함을 보여주는 그래프이다.
FIG. 1 is a schematic diagram of a genome of a recombinant virus using a strain of foot-and-mouth disease type A Korean isolate.
Fig. 2 is a schematic diagram of a plasmid (pA-Kor-Poc) into which the whole gene of the foot-and-mouth disease type A isolate of Korea is inserted.
FIG. 3 shows that the protein expressed in the recombinant FMDV according to the present invention shows a FMD-positive reaction using a liver antigen kit.
4 is a photograph showing virus-infected cells (detection of fluorescent antibody method) and cytopathic effect in foot-and-mouth disease virus infected cells.
FIG. 5 is a graph showing that recombinant foot-and-mouth disease virus according to the present invention grows in a fetal tongue cell line (ZZ-R), a porcine kidney cell line (IBRS-2) and a hamster cell line (BHK-21) to form a virus titer.

본 발명은 적어도 진뱅크 억세션 넘버 KC588943의 염기서열을 갖는 구제역 A형 한국 분리 바이러스(A/KOR/Pocheon/2010)의 전체 유전자가 삽입된 플라스미드를 포함하고, 구제역 A형 아시아 지역형에 대한 방어 면역능을 갖는 것을 특징으로 하는 재조합 구제역 바이러스에 관한 것이다.The present invention includes a plasmid into which a whole gene of a foot-and-mouth disease type A isolate Korean isolate virus (A / KOR / Pocheon / 2010) having a nucleotide sequence of at least a genbank-buster session number KC588943 is inserted, The present invention relates to a recombinant foot-and-mouth disease virus having an immunological ability.

본 발명의 재조합 구제역 바이러스에서, 상기 재조합 유전자가 삽입된 플라스미드는 서열번호 1의 염기서열을 갖는 것을 특징으로 한다. In the recombinant FMD virus of the present invention, the plasmid into which the recombinant gene is inserted is characterized by having the nucleotide sequence of SEQ ID NO: 1.

본 발명의 재조합 구제역 바이러스에서, 상기 구제역 A형 아시아 지역형은 Sea-97 유전자형인 것을 특징으로 한다. In the recombinant foot-and-mouth disease virus of the present invention, the foot-and-mouth disease type A Asian type is a Sea-97 genotype.

본 발명의 재조합 구제역 바이러스에서, 상기 재조합 바이러스는 구제역 백신용 바이러스인 것을 특징으로 한다.In the recombinant foot-and-mouth virus of the present invention, the recombinant virus is characterized by being a foot-and-mouth disease-backing virus.

또한, 본 발명은 (1) 진뱅크 억세션 넘버 KC588943의 염기서열을 갖는 구제역 A형 한국 분리 바이러스의 전체 유전자를 플라스미드에 삽입하는 단계, 및 (2) 상기 (1) 단계에서 얻은 플라스미드를 세포에 주입하여 증식시키는 단계를 포함하는 재조합 구제역 바이러스의 제조방법에 관한 것이다.The present invention also relates to a method for producing a recombinant virus comprising the steps of: (1) inserting a whole gene of foot-and-mouth disease type A isolate virus having the nucleotide sequence of KC588943 in a plasmid; and (2) introducing the plasmid obtained in the above step And a method for producing recombinant foot-and mouth disease virus.

상기에서 구제역 A형 한국 분리 바이러스의 전체 유전자를 플라스미드에 삽입하는 단계는 통상적으로 유전자를 플라스미드에 삽입하는 방법을 이용할 수 있으면 족하므로, 이에 대한 자세한 내용은 생략하기로 한다.The step of inserting the whole gene of foot-and-mouth disease type A isolate virus into the plasmid may be performed by inserting a gene into a plasmid, so that detailed description thereof will be omitted.

본 발명의 재조합 구제역 바이러스의 제조방법에서, 상기 (1) 단계에서 구축된 재조합 플라스미드를 세포에 주입하는 상기 (2) 단계에서의 세포는 염소 태아 혀 세포(ZZ-R), 돼지 신장 세포주(IBRS-2) 및 햄스터 세포주(BHK-21) 중에서 선택된 어느 하나 이상을 사용할 수 있다. In the method for producing recombinant foot-and-mouth disease virus according to the present invention, the cells in the step (2) for injecting the recombinant plasmid constructed in the above step (1) into the cells are selected from the group consisting of fetal tongue cells ZZ- -2) and a hamster cell line (BHK-21) can be used.

본 발명의 재조합 구제역 바이러스의 제조방법에서, 상기 재조합 바이러스는 구제역 A형 아시아 지역형에 대한 방어 면역능을 갖는 것을 특징으로 한다. In the method for producing recombinant foot-and-mouth virus according to the present invention, the recombinant virus is characterized by having defense immunity against the foot-and-mouth disease type A Asian region type.

또한, 본 발명은 상기 재조합 구제역 바이러스를 포함하는 구제역 예방용 백신에 관한 것이다. The present invention also relates to a vaccine for the prevention of foot-and-mouth disease including the recombinant foot-and-mouth disease virus.

본 발명의 상기 백신은 약독 생백신이거나 불활화된 백신일 수 있고, 상기 백신을 제조하는 방법은 통상적인 백신의 제조방법을 이용할 수 있으면 족하므로, 이에 대한 자세한 내용은 생략하기로 한다. The vaccine of the present invention may be a vaccine live vaccine or an inactivated vaccine, and the vaccine may be manufactured using conventional vaccine production methods, so that detailed description thereof will be omitted.

이하 본 발명의 내용을 실험예를 통하여 구체적으로 설명한다. 그러나, 하기의 실험예는 본 발명을 보다 상세하게 설명하기 위한 것으로 본 발명의 권리범위가 이들에 의해 한정되는 것은 아니다.
Hereinafter, the content of the present invention will be described in detail through experimental examples. However, the following experimental examples are intended to illustrate the present invention in more detail, and the scope of the present invention is not limited thereto.

<실시예 1> 재조합 플라스미드 pA-Kor-Poc의 제작Example 1 Preparation of Recombinant Plasmid pA-Kor-Poc

구제역 A형 한국 분리 바이러스(A/KOR/Pocheon/2010)의 전체 유전자(진뱅크 억세션 넘버 KC588943를 PCR에 의하여 증폭하고, 플라스미드(pBluescript SK II)에 상기 A/KOR/Pocheon/2010의 유전자를 삽입하여 재조합 플라스미드 pA-Kor-Poc를 제작하였다. The gene of A / KOR / Pocheon / 2010 in the foot-and-mouth disease virus (A / KOR / Pocheon / 2010) was amplified by PCR and the gene of A / KOR / Pocheon / 2010 in the plasmid (pBluescript SK II) To construct a recombinant plasmid pA-Kor-Poc.

상기에서, PCR 증폭은 다음과 같은 방법으로 실시하였다.In the above, PCR amplification was carried out in the following manner.

일반적으로 cDNA 합성시 사용되는 랜덤 프라이머를 이용하여 상기 한국 분리 바이러스에 대한 cDNA 작성후 이것을 이용하여 한국 분리 바이러스 유전자 정보를 기초로 증폭이 가능한 특이 프라이머들(GenBank Accession No. KC588943)을 기초로 5' 및 3' 유전자의 각 20 mers씩에 해당)를 작성하여 PCR을 실시하였으며, PCR를 위한 조건은 5X buffer (FINNZYMES, 10㎕), 10mM dNTPs (1㎕), Phusion enzyme (2U/㎕, 0.5㎕), 멸균증류수 (35.5㎕)의 용량으로 98℃ 30초 후 98℃ 10초, 65℃ 30초, 72℃ 2분 30초간 25 싸이클, 최종 72℃ 10분으로 반응을 실시하였다.Generally, a random primer used in cDNA synthesis is used to prepare cDNA for the Korean isolate virus, and then 5 '(5'-5' ') nucleotides based on specific primers (GenBank Accession No. KC588943) And 10 μl of 10 mM dNTPs (1 μl), Phusion enzyme (2 μl / μl, 0.5 μl each) was used for the PCR. ) And sterilized distilled water (35.5 占 퐇) at 98 占 폚 for 30 seconds, followed by 25 cycles at 98 占 폚 for 10 seconds, 65 占 폚 for 30 seconds, 72 占 폚 for 2 minutes and 30 seconds, and final 72 占 폚 for 10 minutes.

도 1은 구제역 A형 한국 분리 바이러스의 전체 유전자가 삽입된 플라스미드(pA-Kor-Poc)의 모식도를 나타낸 것이다. 상기 재조합 플라스미드 pA-Kor-Poc는 서열번호 1의 염기서열을 갖는다.
Fig. 1 is a schematic diagram of a plasmid (pA-Kor-Poc) into which the whole gene of foot-and-mouth disease type A isolate virus has been inserted. The recombinant plasmid pA-Kor-Poc has the nucleotide sequence of SEQ ID NO: 1.

<실시예 2> 재조합 구제역 바이러스의 회복&Lt; Example 2 > Recovery of recombinant foot-and-mouth disease virus

재조합 구제역 바이러스의 회복은 확보된 상기 재조합 플라스미드(pA-Kor-Poc)를 제한효소로 반응시킨 뒤, BHKT7-9 세포(T7 RNA polymerase가 발현되는 세포주)에서 바이러스를 확보한 후, ZZ-R(염소 태아 혀) 세포, 돼지 신장 세포주(IBRS-2) 및 BHK-21(햄스터 세포주)에서 증식시키고, BHK-21 세포에서 세포변성 효과를 확인하였다.After recovering the recombinant foot-and-mouth disease virus, the recombinant plasmid (pA-Kor-Poc) was reacted with a restriction enzyme, and the virus was obtained from BHKT7-9 cells (cell line expressing T7 RNA polymerase) (IBRS-2) and BHK-21 (hamster cell line), and the cytopathic effect was confirmed in BHK-21 cells.

도 2는 구제역 A형 한국 분리주의 전체 유전자가 삽입된 플라스미드(pA-Kor-Poc)의 모식도를 나타낸 것이다.Fig. 2 is a schematic diagram of a plasmid (pA-Kor-Poc) into which the whole gene of the foot-and-mouth disease type A isolate of Korea is inserted.

도 3은 간이 항원 킷트를 이용하여 본 발명에 의한 재조합 구제역 바이러스에서 발현된 단백질이 구제역 항원 양성 반응을 보임을 나타낸 것이다. 회복된 바이러스 배양 상층액 25㎕를 간이항원 키트(PBM Co. Ltd.)로 구제역에 대한 구조 단백질(SP)에 대한 양성반응을 확인할 수 있다. FIG. 3 shows that the protein expressed in the recombinant FMDV according to the present invention shows a FMD-positive reaction using a liver antigen kit. 25 μl of the recovered viral culture supernatant can be confirmed with a positive antigen kit (PBM Co. Ltd.) for a positive response to the structural protein (SP) against foot-and-mouth disease.

도 4는 구제역 바이러스가 감염된 세포에서의 바이러스 감염세포(형광항체법 검출) 및 세포변성효과를 보여주는 사진이다. 실험실에서 회복되어 재형성된 바이러스가 세포에 감염되어 형광항체법으로 바이러스의 감염을 검출가능하였고, 세포를 변성시키는 효과도 보였다. 4 is a photograph showing virus-infected cells (detection of fluorescent antibody method) and cytopathic effect in foot-and-mouth disease virus infected cells. Recovered viruses in the laboratory were infected with the cells, so that they could detect virus infection by fluorescence antibody method and showed the effect of denaturing the cells.

도 5는 본 발명에 의한 재조합 구제역 바이러스가 염소 태아 혀 세포주(ZZ-R), 돼지 신장 세포주(IBRS-2) 및 햄스터 세포주(BHK-21)에서 자라서 바이러스 역가를 형성함을 보여주는 그래프이다. 도 5를 참조하면, 본 발명의 재조합 구제역 바이러스는 야외 바이러스와 유사한 바이러스 역가를 나타냄을 알 수 있다.FIG. 5 is a graph showing that recombinant foot-and-mouth disease virus according to the present invention grows in a fetal tongue cell line (ZZ-R), a porcine kidney cell line (IBRS-2) and a hamster cell line (BHK-21) to form a virus titer. Referring to FIG. 5, the recombinant foot-and-mouth disease virus of the present invention shows a virus titer similar to that of an outdoor virus.

상술한 바와 같이 본 발명의 바람직한 실시예 및 시험예를 참조하여 설명하였지만 본 발명의 기술 분야에서 통상의 지식을 가진 통상의 기술자라면 하기의 특허청구범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다. Although the present invention has been described and illustrated in detail, it should be understood by those skilled in the art that various changes and modifications may be made without departing from the scope of the present invention as defined by the appended claims. It will be understood that various modifications and changes may be made in the present invention.

구제역 A형 아시아 지역형에 대한 방어 면역능을 보유하는 본 발명에 의한 재조합 구제역 바이러스를 이용한 구제역 백신을 제공함으로써, 구제역의 치료 및/또는 예방에 기여할 수 있다. Foot-and-mouth disease A Type Foot-and-mouth disease vaccine using the recombinant foot-and-mouth disease virus according to the present invention having defense immunity against Asian type can contribute to treatment and / or prevention of foot-and-mouth disease.

<110> Animal, Plant and Fisheries Quarantine and Inspection Agency <120> Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method <160> 1 <170> KopatentIn 1.71 <210> 1 <211> 11040 <212> DNA <213> Artificial Sequence <220> <223> recombinant plasmid pA-Kor-Poc <400> 1 tatgtaatac gactcactat agggttgaaa gggggcgtta gggtcccacc cctagcatgc 60 caacgactgc tcctgcgttg cactccacac ttacgttcgt gtacgcggga accgatagac 120 taccgttcac ccacctgcag ctggactcat gacaccgcgt ggtcatttag ctggattgtg 180 cggacgaaca ccgcttgcgc acctcgcgtg accgattagt actctcacca ccttccgcct 240 acttggtcgt cagcgctgtc ctgggcaccc ctgttggggg ccgctcgatg ctctacggtt 300 tcccccgcag cgggctacgg tgatggggcc gcctcgtgcg ggttgatcgt ttggtgtgcc 360 tcggttgtga tccgaagctc acctttcatc cccccccccc cccctaagca ctaccgtcgt 420 tcccgacgtt aaagggatga aactacaagc ttagcgcctt cgtgtccgaa gtcaaaggac 480 tacaaccgca agtttgagcc gccttttccg gtgttaatgg aatgtaacca caagatggac 540 cttcttccgg aagtaaaacg gtaatctcac acagttttgc ccgttttcat gagaaatggg 600 acgtctgcgc acgaaacgcg ccgtcgcttg aggaggactt gtacaaacac gatctacgca 660 ggtctccaca actgacacag aacgtgcaac ttggaacccc gcctggtctt tccaggtcta 720 gaggggagac actttgtact gtgcctgact ccacgctcgg tccactggcg agtgttagta 780 gcggcactgt tgcttcgtag cggagcatga cggccgcggg aatccctcct tggtgacaag 840 gacccgcggg gccgaaagcc acgtcccacg gacccgtcat gtgtgcaacc ccagcacggc 900 aactttgcct cgaaacccac ttaaaggtga cactgatact ggtactcagt cactggtgac 960 aggctaagga tgcccttcag gtaccccgag gtaacaagcg acactcggga tctgagaagg 1020 ggactggggc ttctataaaa gcgcccagtt taaaaagctt ctatgcctgg ataggcgatc 1080 ggaggccggc gcctttcctt aattatcact acctttatga acacgactga ctgctttacc 1140 gctctgttgt acgccatcag agagattaag gcacgattct tttccaggac acaagagaaa 1200 atggaattca ctctttacaa cggtgagaag aaaacttttt actctaggcc caacaaccac 1260 gacaactgtt ggttgaacac catcctccaa ctgtttaggt acgtcgacga accattcttc 1320 gactgggtct atgaatcacc tgagaacctc acttttgagg cgattaaaca attggaacag 1380 gtcactggtc ttgagctgcg cgagggtggc ccacccgccc tcgtaatttg gaacattaag 1440 cacttgctcc acaccggaat cggtaccgcc tcgcgaccta gtgaggtgtg tatggtagac 1500 gggacggaca tgtgtctggc tgatttccat gctggcattt tcctgaaagg gcaggaacac 1560 gcagtgtttg cctgtgttac ctccaacggg tggtacgcaa ttgacgacga ggacttttac 1620 ccctggacac cagacccgtc tgatgtcctg gtgtttgtcc cgtatgatca agaaccactc 1680 aacggagaat ggaaaacaaa ggttcagagg cgacttaaag gggcagggca atctagccct 1740 gccaccgggt cacagaacca gtcaggcaat accggcagca ttattaacaa ctactacatg 1800 cagcagtacc agaactccat ggacacacaa cttggtgaca acgccatcag cggaggatcc 1860 aacgaggggt ccacggacac aacctctacc cacacaacca acacccaaaa caatgactgg 1920 ttctcaaaac tggcaagttc cgcgttcacc ggtcttttcg gcgcactgct cgccgacaag 1980 aagaccgaag agacaactct tctggaggac cgtatcctca ccactcgtaa tggacacacc 2040 acttctacaa ctcagtcgag tgtgggggtc acctacgggt attcaactgg tgaggaccac 2100 gtttctggac ctaacacatc aggtttggag acgcgggtgg tacaagctga aaggttcttc 2160 aagaagcact tgtttgattg gacgacggac aaaccctttg gtcacgttga aaagctggaa 2220 cttcccactg atcacaaagg tgtctacgga cagctggtgg actcctttgc atacatgaga 2280 aatggctggg acgtggaggt gtctgctgtt ggcaaccagt tcaacggcgg gtgccttctc 2340 gtggccatgg tacctgagtt taaggagttc accacacgtg aaaagtacca gctcaccctg 2400 ttcccccacc agttcattag ccccagaacc aacatgaccg cgcacatcac ggtcccgtac 2460 cttggtgtga acaggtatga ccagtacaac aaacacaaac cctggacgtt ggtggtgatg 2520 gtggtttcac cacttaccac tagctccatt ggtgcatcac agattaaggt ctacaccaat 2580 atcgccccta cccacgttca cgtggctggc gagctcccgt cgaaagaggg gatcgtgccg 2640 gtcgcctgct cggacgggta cggtggcctg gtgacaacag accctaaaac agctgaccct 2700 gcttacggta tggtgtacaa cccacctagg accaactacc ccgggcggtt tacaaacttg 2760 ttggacgtgg cagaggcgtg tcccaccttc ctctgtttcg acgacgggaa accgtatgtt 2820 gtgacaagag cggatgagca gcgcctcttg gccaagtttg acctttccct tgctgcaaag 2880 cacatgtcaa acacctacct ttcagggata gcacagtact acgcacagta ctctggcacc 2940 atcaatttgc acttcatgtt tactggttcc actgactcaa aggcccgtta catggtggct 3000 tacgtcccgc ctggcgtgac aacgccaccg gacacgcctg agagagctgc gcactgcatc 3060 cacgcagaat gggacacggg cctaaactcc aaattcactt tttcaatccc gtacgtatct 3120 gctgcagatt acgcgtacac agcgtccgat gtggcagaca caacaaacgt acagggatgg 3180 gtttgcatct accaaatcac ccacgggaag gccgaacaag acactttggt cgtgtcggtc 3240 agcgccggca aagactttga gctgcgcctc cccattgacc cccgtgcgca aaccaccgcc 3300 accggggaat cagcagaccc cgtcacaacc accgtcgaga actacggtgg tgagacacaa 3360 gtgcagcgac gccaccacac cgacgtcagc tttataatgg acaggtttgt gcagatcaag 3420 cctgtgagcc ccacacatgt cattgacctc atgcaaacac accaacacgg gctggtaggc 3480 gctatgttgc gcgcggccac ctactacttt tctgatcttg agattgtggt gaaccacaca 3540 ggtcgcctaa cgtgggtacc caatggagca ccagaggcag cactggataa cacgagcaac 3600 cccactgctt accacaaagc accgttcaca aggcttgcac tcccttacac cgcgccacac 3660 cgcgtgttgg caaccgtgta caacgggact agcaggtact ctgcgcctgc aacacggcga 3720 ggtgacttgg ggtctctcgc ggcgaggctc gccgcacagc ttcctgcctc cttcaactac 3780 ggcgcggttc gagccacgga gatccaagaa ctcctcgtgc gcatgaagcg cgccgagctc 3840 tactgcccca ggccactgct ggcggtggag gtgacgtcac aagacagaca caagcagaaa 3900 atcattgccc ctgcaaagca actcctgaac cttgatctgc tcaagttggc gggagacgtt 3960 gagtccaacc ctgggccttt cttcttctcc gacgttaggt caaatttcac caaactggtt 4020 gaaaccatta accagatgca agaggacatg tcaacaaaac acgggcctga ctttagccgg 4080 ttggtgtccg cgtttgagga attggccgcc ggggtgaaag ccatcaggaa cggtctcgac 4140 gaggccaagc cctggtataa gctcatcaaa ctcctaagcc gcttgtcatg catggccgct 4200 gtagcagcac ggtccaagga cccagtcctt gtggccatca tgctggctga caccggcctt 4260 gagattctgg acagcacgtt tgtcgtgaag aagatctccg actcgctctc cagtctcttt 4320 cacgtgccgg cccccgtctt tagtttcgga gctccgatcc tattggctgg gttggtcaag 4380 gtcgcctcga gtttcttccg gtccacgccc gaagaccttg agagagcaga aaaacagctc 4440 aaagcacgtg acatcaatga catattcgcc attctcaaga acggcgagtg gctggtcaag 4500 ctgatcctag ctatccgcga ctggattaaa gcatggatcg cctcagaaga aaagtttgtc 4560 accatgacag acttggtgcc tggtatcctt gaaaagcagc gggatctcaa cgacccgagc 4620 aagtacaagg cagccaagga gtggcttgac aacgcgcgtc aagcgtgcct gaagagcggg 4680 aatgtccaca ttgccaacct ttgcaaagtg gtcgccccag cgccaagcaa gtcgagaccc 4740 gaacccgtgg tcgtttgcct ccgtggcaaa tccggccagg gcaaaagttt ccttgcgaac 4800 gtgctcgcac aagcaatttc aacccacttc actggcagaa tcgattcagt ttggtactgc 4860 ccacctgacc ctgaccactt cgacggttat aaccaacaaa ccgttgttgt gatggacgat 4920 ttgggccaga accccgacgg caaggacttt aagtacttcg cccagatggt ttcaaccacg 4980 gggttcatcc cgcccatggc ctcacttgag gacaagggga aacccttcaa cagcaaagtc 5040 atcattacca ccaccaacct ctatgcgggc tttaccccga gaaccatggt gtgtcctgac 5100 gcgctgaacc ggaggttcca ctttgacatt gatgtgagtg ccaaggacgg gtacaaaatt 5160 aacaacaaat tggacataat caaagcactt gaagacacac acaccaaccc ggtagcaatg 5220 ttccagtacg actgcgccct cctcaacggc atggcagtcg agatgaagag attgcaacag 5280 gatttgttca ctccccaacc acccatacag aatgtttacc aacttgttca agaagtgatt 5340 gatcgggtgg agctccacga gaaagtgtcg agccacccga ttttcaaaca gatctcaatt 5400 ccttcccaaa agtctgtgct gtactttctc attgagaaag gccaacacga ggcagcaatt 5460 gaattctttg aggggatggt gcatgactcc atcaaggagg agctccggcc cctcatccaa 5520 caaacctcat ttgtgaaacg cgctttcagg cgcctgaagg aaaactttga ggtcgttgcc 5580 ctgtgtttga ctctcttggc aaacatagtg atcatgatcc gcgaaactcg taagagacaa 5640 caaatggtgg atgatgcggt gaatgagtac attgagaagg caaacatcac cacagatgac 5700 aaaactcttg acgaggcgga aaagaaccct ctggagacta gcggtgccag cactgttggc 5760 ttcagagaga gatctctccc cggacataaa gtgagcgacg acgtgaactc cgagcccacc 5820 aaacccgcgg gaggacaacc acaagctgaa ggaccctgcg ccggaccgct tgagcgtcag 5880 aaacctctga aagtgaaagc caagctgcca caacaggagg gaccctacgc tggtccgatg 5940 gagagacaga aaccactgaa agtgaaagta aaagccccgg tcgtgaagga aggaccctac 6000 gaaggaccgg tgaagaagcc tgtcgctttg aaagtaaaag ctaagaacct gattgtcact 6060 gaaagtggtg cccccccgac cgacttgcaa aagatggtta tgggcaacac caaacccgtt 6120 gagcttatcc tcgatgggaa gacagtagcc atctgctgcg ctactggagt gttcggcact 6180 gcctacctcg tgcctcgtca tcttttcgct gagaagtatg acaagatcat gttggatggt 6240 agagccatga cagacagtga ctacagagtg tttgagtttg aaattaaggt aaaaggacag 6300 gacatgcttt cagacgctgc gctcatggtg ttgcaccgtg ggaatcgcgt gagagatatc 6360 acgaaacact ttcgtgacac agcaagaatg aagaaaggca cctccgtcgt cggcgtaata 6420 aacaacgctg atgttggtag actgattttc tctggtgagg cccttaccta caaagacatt 6480 gtagtgtgca tggatggaga caccatgccg ggcttgtttg cctacagagc cgccaccaag 6540 gctggttact gtggaggagc tgttcttgcc aaagacggag ctgacacatt catcgtcggc 6600 actcactccg caggtggtaa tggggttggg tactgctcgt gcgtatccag atccatgctt 6660 ttgaagatga aggcacacat tgaccctgag ccacaccatg aagggttgat tgttgacacc 6720 agggatgtgg aagagcgcgt gcacgtcatg cgtaaaacca agcttgcgcc caccgtggct 6780 cacggtgtgt tcaaccccga gtacggcccc gctgccttgt ccaacaagga tccgcggctg 6840 aatgagggag ttgtcctcga cgaggtcatc ttctccaaac ataagggaga cacaaggatg 6900 tcaccggagg ataaagcgct gttccgccgc tgtgctgccg actacgcgtc gcgtttgcac 6960 ggtgtgctgg gtacggcaaa tgccccattg agcgtctatg aggccatcaa gggtgtcgac 7020 ggacttgacg ccatggaacc tgacacagca cctggccttc cctgggccct ccaggggaag 7080 cgtcgtggcg cgctggttga ctttgagaac ggcacggtcg ggcccgaagt ccaggctgct 7140 ctagagctca tggagaaaag agaatacaag tttgcttgcc agaccttcct gaaggacgag 7200 attcgcccga tggaaaaagt acgtgccggc aagactcgta ttgtcgatgt cttgcctgtt 7260 gaacacattc tttacactag gatgatgatt ggcagatttt gtgcacaaat gcactcaaac 7320 aacggcccgc aaattggatc agcggtcggc tgtaatcctg atgttgattg gcaaagattc 7380 ggaacacact tcgcccaata caggaacgtg tgggatgtgg actattcggc cttcgatgct 7440 aaccactgca gtgatgcaat gaacatcatg tttgaggagg tgtttcgcac agactttggt 7500 ttccacccga acgctgagtg gattctgaag actcttgtga atacggaaca cgcctatgaa 7560 aacaaacgca ttactgttga aggcgggatg ccatcaggtt gttccgcgac aagcatcatt 7620 aacacaattt tgaacaacat ttacgtgctc tacgccctgc gtagacacta tgagggagtt 7680 gagctggaca cttacaccat gatctcctat ggggacgaca tcgtggtcgc aagtgattac 7740 gatctggact ttgaggctct caagccccac ttcaaatctc ttggtcaaac catcacccca 7800 gctgacaaaa gcgacaaagg ttttgttctt ggtcactcca tcaccgatgt cactttcctc 7860 aaaagacact ttcacatgga ctacggaact gggttttaca aacctgtgat ggcttcgaag 7920 accctcgaag ctatcctctc ctttgcacgc cgtgggacca tacaggagaa gttgatctcc 7980 gtggcaggac tcgccgtcca ctctggaccc gacgagtatc ggcgtctctt tgagcccttc 8040 cagggtctct ttgagattcc aagctacaga tcactttacc tgcgatgggt gaacgccgtg 8100 tgtggcgacg cataatccct cagaagtcac aattggcaga aagactctga ggcgcgcgac 8160 gccataggag tgaaaagccc gaaaaggctt ttcccgcttc ctatttcaaa aaaaaaaaaa 8220 aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaacta gtaatcatgg tcatagctgt 8280 ttcctgtgtg aaattgttat ccgctcacaa ttccacacaa catacgagcc ggaagcataa 8340 agtgtaaagc ctggggtgcc taatgagtga gctaactcac attaattgcg ttgcgctcac 8400 tgcccgcttt ccagtcggga aacctgtcgt gccagctgca ttaatgaatc ggccaacgcg 8460 cggggagagg cggtttgcgt attgggcgct cttccgcttc ctcgctcact gactcgctgc 8520 gctcggtcgt tcggctgcgg cgagcggtat cagctcactc aaaggcggta atacggttat 8580 ccacagaatc aggggataac gcaggaaaga acatgtgagc aaaaggccag caaaaggcca 8640 ggaaccgtaa aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc 8700 atcacaaaaa tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc 8760 aggcgtttcc ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg 8820 gatacctgtc cgcctttctc ccttcgggaa gcgtggcgct ttctcatagc tcacgctgta 8880 ggtatctcag ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg 8940 ttcagcccga ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac 9000 acgacttatc gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag 9060 gcggtgctac agagttcttg aagtggtggc ctaactacgg ctacactaga aggacagtat 9120 ttggtatctg cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat 9180 ccggcaaaca aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag cagattacgc 9240 gcagaaaaaa aggatctcaa gaagatcctt tgatcttttc tacggggtct gacgctcagt 9300 ggaacgaaaa ctcacgttaa gggattttgg tcatgagatt atcaaaaagg atcttcacct 9360 agatcctttt aaattaaaaa tgaagtttta aatcaatcta aagtatatat gagtaaactt 9420 ggtctgacag ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc tgtctatttc 9480 gttcatccat agttgcctga ctccccgtcg tgtagataac tacgatacgg gagggcttac 9540 catctggccc cagtgctgca atgataccgc gagacccacg ctcaccggct ccagatttat 9600 cagcaataaa ccagccagcc ggaagggccg agcgcagaag tggtcctgca actttatccg 9660 cctccatcca gtctattaat tgttgccggg aagctagagt aagtagttcg ccagttaata 9720 gtttgcgcaa cgttgttgcc attgctacag gcatcgtggt gtcacgctcg tcgtttggta 9780 tggcttcatt cagctccggt tcccaacgat caaggcgagt tacatgatcc cccatgttgt 9840 gcaaaaaagc ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag ttggccgcag 9900 tgttatcact catggttatg gcagcactgc ataattctct tactgtcatg ccatccgtaa 9960 gatgcttttc tgtgactggt gagtactcaa ccaagtcatt ctgagaatag tgtatgcggc 10020 gaccgagttg ctcttgcccg gcgtcaatac gggataatac cgcgccacat agcagaactt 10080 taaaagtgct catcattgga aaacgttctt cggggcgaaa actctcaagg atcttaccgc 10140 tgttgagatc cagttcgatg taacccactc gtgcacccaa ctgatcttca gcatctttta 10200 ctttcaccag cgtttctggg tgagcaaaaa caggaaggca aaatgccgca aaaaagggaa 10260 taagggcgac acggaaatgt tgaatactca tactcttcct ttttcaatat tattgaagca 10320 tttatcaggg ttattgtctc atgagcggat acatatttga atgtatttag aaaaataaac 10380 aaataggggt tccgcgcaca tttccccgaa aagtgccacc taaattgtaa gcgttaatat 10440 tttgttaaaa ttcgcgttaa atttttgtta aatcagctca ttttttaacc aataggccga 10500 aatcggcaaa atcccttata aatcaaaaga atagaccgag atagggttga gtgttgttcc 10560 agtttggaac aagagtccac tattaaagaa cgtggactcc aacgtcaaag ggcgaaaaac 10620 cgtctatcag ggcgatggcc cactacgtga accatcaccc taatcaagtt ttttggggtc 10680 gaggtgccgt aaagcactaa atcggaaccc taaagggagc ccccgattta gagcttgacg 10740 gggaaagccg gcgaacgtgg cgagaaagga agggaagaaa gcgaaaggag cgggcgctag 10800 ggcgctggca agtgtagcgg tcacgctgcg cgtaaccacc acacccgccg cgcttaatgc 10860 gccgctacag ggcgcgtccc attcgccatt caggctgcgc aactgttggg aagggcgatc 10920 ggtgcgggcc tcttcgctat tacgccagct ggcgaaaggg ggatgtgctg caaggcgatt 10980 aagttgggta acgccagggt tttcccagtc acgacgttgt aaaacgacgg ccagtgagca 11040 11040 <110> Animal, Plant and Fisheries Quarantine and Inspection Agency <120> Recombinant foot-and-mouth disease virus using Korean isolated          strain of FMDV serotype and the manufacturing method <160> 1 <170> Kopatentin 1.71 <210> 1 <211> 11040 <212> DNA <213> Artificial Sequence <220> <223> Recombinant plasmid pA-Kor-Poc <400> 1 tatgtaatac gactcactat agggttgaaa gggggcgtta gggtcccacc cctagcatgc 60 caacgactgc tcctgcgttg cactccacac ttacgttcgt gtacgcggga accgatagac 120 taccgttcac ccacctgcag ctggactcat gacaccgcgt ggtcatttag ctggattgtg 180 cggacgaaca ccgcttgcgc acctcgcgtg accgattagt actctcacca ccttccgcct 240 acttggtcgt cagcgctgtc ctgggcaccc ctgttggggg ccgctcgatg ctctacggtt 300 tcccccgcag cgggctacgg tgatggggcc gcctcgtgcg ggttgatcgt ttggtgtgcc 360 tcggttgtga tccgaagctc acctttcatc cccccccccc cccctaagca ctaccgtcgt 420 tcccgacgtt aaagggatga aactacaagc ttagcgcctt cgtgtccgaa gtcaaaggac 480 tacaaccgca agtttgagcc gccttttccg gtgttaatgg aatgtaacca caagatggac 540 cttcttccgg aagtaaaacg gtaatctcac acagttttgc ccgttttcat gagaaatggg 600 acgtctgcgc acgaaacgcg ccgtcgcttg aggaggactt gtacaaacac gatctacgca 660 ggtctccaca actgacacag aacgtgcaac ttggaacccc gcctggtctt tccaggtcta 720 gaggggagac actttgtact gtgcctgact ccacgctcgg tccactggcg agtgttagta 780 gcggcactgt tgcttcgtag cggagcatga cggccgcggg aatccctcct tggtgacaag 840 gacccgcggg gccgaaagcc acgtcccacg gacccgtcat gtgtgcaacc ccagcacggc 900 aactttgcct cgaaacccac ttaaaggtga cactgatact ggtactcagt cactggtgac 960 aggctaagga tgcccttcag gtaccccgag gtaacaagcg acactcggga tctgagaagg 1020 ggactggggc ttctataaaa gcgcccagtt taaaaagctt ctatgcctgg ataggcgatc 1080 ggaggccggc gcctttcctt aattatcact acctttatga acacgactga ctgctttacc 1140 gctctgttgt acgccatcag agagattaag gcacgattct tttccaggac acaagagaaa 1200 atggaattca ctctttacaa cggtgagaag aaaacttttt actctaggcc caacaaccac 1260 gacactgtt ggttgaacac catcctccaa ctgtttaggt acgtcgacga accattcttc 1320 gactgggtct atgaatcacc tgagaacctc acttttgagg cgattaaaca attggaacag 1380 gtcactggtc ttgagctgcg cgagggtggc ccacccgccc tcgtaatttg gaacattaag 1440 cacttgctcc acaccggaat cggtaccgcc tcgcgaccta gtgaggtgtg tatggtagac 1500 gggacggaca tgtgtctggc tgatttccat gctggcattt tcctgaaagg gcaggaacac 1560 gcagtgtttg cctgtgttac ctccaacggg tggtacgcaa ttgacgacga ggacttttac 1620 ccctggacac cagacccgtc tgatgtcctg gtgtttgtcc cgtatgatca agaaccactc 1680 aacggagaat ggaaaacaaa ggttcagagg cgacttaaag gggcagggca atctagccct 1740 gccaccgggt cacagaacca gtcaggcaat accggcagca ttattaacaa ctactacatg 1800 cagcagtacc agaactccat ggacacacaa cttggtgaca acgccatcag cggaggatcc 1860 aacgaggggt ccacggacac aacctctacc cacacaacca acacccaaaa caatgactgg 1920 ttctcaaaac tggcaagttc cgcgttcacc ggtcttttcg gcgcactgct cgccgacaag 1980 aagaccgaag agacaactct tctggaggac cgtatcctca ccactcgtaa tggacacacc 2040 acttctacaa ctcagtcgag tgtgggggtc acctacgggt attcaactgg tgaggaccac 2100 gtttctggac ctaacacatc aggtttggag acgcgggtgg tacaagctga aaggttcttc 2160 aagaagcact tgtttgattg gacgacggac aaaccctttg gtcacgttga aaagctggaa 2220 cttcccactg atcacaaagg tgtctacgga cagctggtgg actcctttgc atacatgaga 2280 aatggctggg acgtggaggt gtctgctgtt ggcaaccagt tcaacggcgg gtgccttctc 2340 gtggccatgg tacctgagtt taaggagttc accacacgtg aaaagtacca gctcaccctg 2400 ttcccccacc agttcattag ccccagaacc aacatgaccg cgcacatcac ggtcccgtac 2460 cttggtgtga acaggtatga ccagtacaac aaacacaaac cctggacgtt ggtggtgatg 2520 gtggtttcac cacttaccac tagctccatt ggtgcatcac agattaaggt ctacaccaat 2580 atcgccccta cccacgttca cgtggctggc gagctcccgt cgaaagaggg gatcgtgccg 2640 gtcgcctgct cggacgggta cggtggcctg gtgacaacag accctaaaac agctgaccct 2700 gcttacggta tggtgtacaa cccacctagg accaactacc ccgggcggtt tacaaacttg 2760 ttggacgtgg cagaggcgtg tcccaccttc ctctgtttcg acgacgggaa accgtatgtt 2820 gtgacaagag cggatgagca gcgcctcttg gccaagtttg acctttccct tgctgcaaag 2880 cacatgtcaa acacctacct ttcagggata gcacagtact acgcacagta ctctggcacc 2940 atcaatttgc acttcatgtt tactggttcc actgactcaa aggcccgtta catggtggct 3000 tacgtcccgc ctggcgtgac aacgccaccg gacacgcctg agagagctgc gcactgcatc 3060 cacgcagaat gggacacggg cctaaactcc aaattcactt tttcaatccc gtacgtatct 3120 gctgcagatt acgcgtacac agcgtccgat gtggcagaca caacaaacgt acagggatgg 3180 gtttgcatct accaaatcac ccacgggaag gccgaacaag acactttggt cgtgtcggtc 3240 agcgccggca aagactttga gctgcgcctc cccattgacc cccgtgcgca aaccaccgcc 3300 accggggaat cagcagaccc cgtcacaacc accgtcgaga actacggtgg tgagacacaa 3360 gtgcagcgac gccaccacac cgacgtcagc tttataatgg acaggtttgt gcagatcaag 3420 cctgtgagcc ccacacatgt cattgacctc atgcaaacac accaacacgg gctggtaggc 3480 gctatgttgc gcgcggccac ctactacttt tctgatcttg agattgtggt gaaccacaca 3540 ggtcgcctaa cgtgggtacc caatggagca ccagaggcag cactggataa cacgagcaac 3600 cccactgctt accacaaagc accgttcaca aggcttgcac tcccttacac cgcgccacac 3660 cgcgtgttgg caaccgtgta caacgggact agcaggtact ctgcgcctgc aacacggcga 3720 ggtgacttgg ggtctctcgc ggcgaggctc gccgcacagc ttcctgcctc cttcaactac 3780 ggcgcggttc gagccacgga gatccaagaa ctcctcgtgc gcatgaagcg cgccgagctc 3840 tactgcccca ggccactgct ggcggtggag gtgacgtcac aagacagaca caagcagaaa 3900 atcattgccc ctgcaaagca actcctgaac cttgatctgc tcaagttggc gggagacgtt 3960 gagtccaacc ctgggccttt cttcttctcc gacgttaggt caaatttcac caaactggtt 4020 gaaaccatta accagatgca agaggacatg tcaacaaaac acgggcctga ctttagccgg 4080 ttggtgtccg cgtttgagga attggccgcc ggggtgaaag ccatcaggaa cggtctcgac 4140 gaggccaagc cctggtataa gctcatcaaa ctcctaagcc gcttgtcatg catggccgct 4200 gtagcagcac ggtccaagga cccagtcctt gtggccatca tgctggctga caccggcctt 4260 gagattctgg acagcacgtt tgtcgtgaag aagatctccg actcgctctc cagtctcttt 4320 cacgtgccgg cccccgtctt tagtttcgga gctccgatcc tattggctgg gttggtcaag 4380 gtcgcctcga gtttcttccg gtccacgccc gaagaccttg agagagcaga aaaacagctc 4440 aaagcacgtg acatcaatga catattcgcc attctcaaga acggcgagtg gctggtcaag 4500 ctgatcctag ctatccgcga ctggattaaa gcatggatcg cctcagaaga aaagtttgtc 4560 accatgacag acttggtgcc tggtatcctt gaaaagcagc gggatctcaa cgacccgagc 4620 aagtacaagg cagccaagga gtggcttgac aacgcgcgtc aagcgtgcct gaagagcggg 4680 aatgtccaca ttgccaacct ttgcaaagtg gtcgccccag cgccaagcaa gtcgagaccc 4740 gaacccgtgg tcgtttgcct ccgtggcaaa tccggccagg gcaaaagttt ccttgcgaac 4800 gtgctcgcac aagcaatttc aacccacttc actggcagaa tcgattcagt ttggtactgc 4860 ccacctgacc ctgaccactt cgacggttat aaccaacaaa ccgttgttgt gatggacgat 4920 ttgggccaga accccgacgg caaggacttt aagtacttcg cccagatggt ttcaaccacg 4980 gggttcatcc cgcccatggc ctcacttgag gacaagggga aacccttcaa cagcaaagtc 5040 atcattacca ccaccaacct ctatgcgggc tttaccccga gaaccatggt gtgtcctgac 5100 gcgctgaacc ggaggttcca ctttgacatt gatgtgagtg ccaaggacgg gtacaaaatt 5160 aacaacaaat tggacataat caaagcactt gaagacacac acaccaaccc ggtagcaatg 5220 ttccagtacg actgcgccct cctcaacggc atggcagtcg agatgaagag attgcaacag 5280 gatttgttca ctccccaacc acccatacag aatgtttacc aacttgttca agaagtgatt 5340 gatcgggtgg agctccacga gaaagtgtcg agccacccga ttttcaaaca gatctcaatt 5400 ccttcccaaa agtctgtgct gtactttctc attgagaaag gccaacacga ggcagcaatt 5460 gaattctttg aggggatggt gcatgactcc atcaaggagg agctccggcc cctcatccaa 5520 caaacctcat ttgtgaaacg cgctttcagg cgcctgaagg aaaactttga ggtcgttgcc 5580 ctgtgtttga ctctcttggc aaacatagtg atcatgatcc gcgaaactcg taagagacaa 5640 caaatggtgg atgatgcggt gaatgagtac attgagaagg caaacatcac cacagatgac 5700 aaaactcttg acgaggcgga aaagaaccct ctggagacta gcggtgccag cactgttggc 5760 ttcagagaga gatctctccc cggacataaa gtgagcgacg acgtgaactc cgagcccacc 5820 aaacccgcgg gaggacaacc acaagctgaa ggaccctgcg ccggaccgct tgagcgtcag 5880 aaacctctga aagtgaaagc caagctgcca caacaggagg gaccctacgc tggtccgatg 5940 gagagacaga aaccactgaa agtgaaagta aaagccccgg tcgtgaagga aggaccctac 6000 gaaggaccgg tgaagaagcc tgtcgctttg aaagtaaaag ctaagaacct gattgtcact 6060 gaaagtggtg cccccccgac cgacttgcaa aagatggtta tgggcaacac caaacccgtt 6120 gagcttatcc tcgatgggaa gacagtagcc atctgctgcg ctactggagt gttcggcact 6180 gcctacctcg tgcctcgtca tcttttcgct gagaagtatg acaagatcat gttggatggt 6240 agagccatga cagacagtga ctacagagtg tttgagtttg aaattaaggt aaaaggacag 6300 gacatgcttt cagacgctgc gctcatggtg ttgcaccgtg ggaatcgcgt gagagatatc 6360 acgaaacact ttcgtgacac agcaagaatg aagaaaggca cctccgtcgt cggcgtaata 6420 aacaacgctg atgttggtag actgattttc tctggtgagg cccttaccta caaagacatt 6480 gtagtgtgca tggatggaga caccatgccg ggcttgtttg cctacagagc cgccaccaag 6540 gctggttact gtggaggagc tgttcttgcc aaagacggag ctgacacatt catcgtcggc 6600 actcactccg caggtggtaa tggggttggg tactgctcgt gcgtatccag atccatgctt 6660 ttgaagatga aggcacacat tgaccctgag ccacaccatg aagggttgat tgttgacacc 6720 agggatgtgg aagagcgcgt gcacgtcatg cgtaaaacca agcttgcgcc caccgtggct 6780 cacggtgtgt tcaaccccga gtacggcccc gctgccttgt ccaacaagga tccgcggctg 6840 aatgagggag ttgtcctcga cgaggtcatc ttctccaaac ataagggaga cacaaggatg 6900 tcaccggagg ataaagcgct gttccgccgc tgtgctgccg actacgcgtc gcgtttgcac 6960 ggtgtgctgg gtacggcaaa tgccccattg agcgtctatg aggccatcaa gggtgtcgac 7020 ggacttgacg ccatggaacc tgacacagca cctggccttc cctgggccct ccaggggaag 7080 cgtcgtggcg cgctggttga ctttgagaac ggcacggtcg ggcccgaagt ccaggctgct 7140 ctagagctca tggagaaaag agaatacaag tttgcttgcc agaccttcct gaaggacgag 7200 attcgcccga tggaaaaagt acgtgccggc aagactcgta ttgtcgatgt cttgcctgtt 7260 gaacacattc tttacactag gatgatgatt ggcagatttt gtgcacaaat gcactcaaac 7320 aacggcccgc aaattggatc agcggtcggc tgtaatcctg atgttgattg gcaaagattc 7380 ggaacacact tcgcccaata caggaacgtg tgggatgtgg actattcggc cttcgatgct 7440 aaccactgca gtgatgcaat gaacatcatg tttgaggagg tgtttcgcac agactttggt 7500 ttccacccga acgctgagtg gattctgaag actcttgtga atacggaaca cgcctatgaa 7560 aacaaacgca ttactgttga aggcgggatg ccatcaggtt gttccgcgac aagcatcatt 7620 aacacaattt tgaacaacat ttacgtgctc tacgccctgc gtagacacta tgagggagtt 7680 gagctggaca cttacaccat gatctcctat ggggacgaca tcgtggtcgc aagtgattac 7740 gatctggact ttgaggctct caagccccac ttcaaatctc ttggtcaaac catcacccca 7800 gctgacaaaa gcgacaaagg ttttgttctt ggtcactcca tcaccgatgt cactttcctc 7860 aaaagacact ttcacatgga ctacggaact gggttttaca aacctgtgat ggcttcgaag 7920 accctcgaag ctatcctctc ctttgcacgc cgtgggacca tacaggagaa gttgatctcc 7980 gtggcaggac tcgccgtcca ctctggaccc gacgagtatc ggcgtctctt tgagcccttc 8040 cagggtctct ttgagattcc aagctacaga tcactttacc tgcgatgggt gaacgccgtg 8100 tgtggcgacg cataatccct cagaagtcac aattggcaga aagactctga ggcgcgcgac 8160 gccataggag tgaaaagccc gaaaaggctt ttcccgcttc ctatttcaaa aaaaaaaaaa 8220 aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaacta gtaatcatgg tcatagctgt 8280 ttcctgtgtg aaattgttat ccgctcacaa ttccacacaa catacgagcc ggaagcataa 8340 agtgtaaagc ctggggtgcc taatgagtga gctaactcac attaattgcg ttgcgctcac 8400 tgcccgcttt ccagtcggga aacctgtcgt gccagctgca ttaatgaatc ggccaacgcg 8460 cggggagagg cggtttgcgt attgggcgct cttccgcttc ctcgctcact gactcgctgc 8520 gctcggtcgt tcggctgcgg cgagcggtat cagctcactc aaaggcggta atacggttat 8580 ccacagaatc aggggataac gcaggaaaga acatgtgagc aaaaggccag caaaaggcca 8640 ggaaccgtaa aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc 8700 atcacaaaaa tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc 8760 aggcgtttcc ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg 8820 gatacctgtc cgcctttctc ccttcgggaa gcgtggcgct ttctcatagc tcacgctgta 8880 ggtatctcag ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg 8940 ttcagcccga ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac 9000 acgacttatc gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag 9060 gcggtgctac agagttcttg aagtggtggc ctaactacgg ctacactaga aggacagtat 9120 ttggtatctg cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat 9180 ccggcaaaca aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag cagattacgc 9240 gcagaaaaaa aggatctcaa gaagatcctt tgatcttttc tacggggtct gacgctcagt 9300 ggaacgaaaa ctcacgttaa gggattttgg tcatgagatt atcaaaaagg atcttcacct 9360 agatcctttt aaattaaaaa tgaagtttta aatcaatcta aagtatatat gagtaaactt 9420 ggtctgacag ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc tgtctatttc 9480 gttcatccat agttgcctga ctccccgtcg tgtagataac tacgatacgg gagggcttac 9540 catctggccc cagtgctgca atgataccgc gagacccacg ctcaccggct ccagatttat 9600 cagcaataaa ccagccagcc ggaagggccg agcgcagaag tggtcctgca actttatccg 9660 cctccatcca gtctattaat tgttgccggg aagctagagt aagtagttcg ccagttaata 9720 gtttgcgcaa cgttgttgcc attgctacag gcatcgtggt gtcacgctcg tcgtttggta 9780 tggcttcatt cagctccggt tcccaacgat caaggcgagt tacatgatcc cccatgttgt 9840 gcaaaaaagc ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag ttggccgcag 9900 tgttatcact catggttatg gcagcactgc ataattctct tactgtcatg ccatccgtaa 9960 gatgcttttc tgtgactggt gagtactcaa ccaagtcatt ctgagaatag tgtatgcggc 10020 gaccgagttg ctcttgcccg gcgtcaatac gggataatac cgcgccacat agcagaactt 10080 taaaagtgct catcattgga aaacgttctt cggggcgaaa actctcaagg atcttaccgc 10140 tgttgagatc cagttcgatg taacccactc gtgcacccaa ctgatcttca gcatctttta 10200 ctttcaccag cgtttctggg tgagcaaaaa caggaaggca aaatgccgca aaaaagggaa 10260 taagggcgac acggaaatgt tgaatactca tactcttcct ttttcaatat tattgaagca 10320 tttatcaggg ttattgtctc atgagcggat acatatttga atgtatttag aaaaataaac 10380 aaataggggt tccgcgcaca tttccccgaa aagtgccacc taaattgtaa gcgttaatat 10440 tttgttaaaa ttcgcgttaa atttttgtta aatcagctca ttttttaacc aataggccga 10500 aatcggcaaa atcccttata aatcaaaaga atagaccgag atagggttga gtgttgttcc 10560 agtttggaac aagagtccac tattaaagaa cgtggactcc aacgtcaaag ggcgaaaaac 10620 cgtctatcag ggcgatggcc cactacgtga accatcaccc taatcaagtt ttttggggtc 10680 gaggtgccgt aaagcactaa atcggaaccc taaagggagc ccccgattta gagcttgacg 10740 gggaaagccg gcgaacgtgg cgagaaagga agggaagaaa gcgaaaggag cgggcgctag 10800 ggcgctggca agtgtagcgg tcacgctgcg cgtaaccacc acacccgccg cgcttaatgc 10860 gccgctacag ggcgcgtccc attcgccatt caggctgcgc aactgttggg aagggcgatc 10920 ggtgcgggcc tcttcgctat tacgccagct ggcgaaaggg ggatgtgctg caaggcgatt 10980 aagttgggta acgccagggt tttcccagtc acgacgttgt aaaacgacgg ccagtgagca 11040                                                                        11040

Claims (9)

진뱅크 억세션 넘버 KC588943의 염기서열을 갖는 구제역 A형 한국 분리 바이러스(A/KOR/Pocheon/2010)의 전체 유전자가 삽입된 플라스미드를 포함하고, 구제역 A형 아시아 지역형에 대한 방어 면역능을 가지며, 상기 플라스미드는 서열번호 1의 염기서열을 갖는 것을 특징으로 하는 재조합 구제역 바이러스.(A / KOR / Pocheon / 2010) having the nucleotide sequence of the genus Berk et al.'S session number KC588943, having a defense immunity against the foot-and-mouth disease type A Asian region, Wherein the plasmid has the nucleotide sequence of SEQ ID NO: 1. 삭제delete 제1항에 있어서, 상기 구제역 A형 아시아 지역형은 Sea-97 유전자형인 것을 특징으로 하는 재조합 구제역 바이러스.The recombinant foot-and-mouth disease virus according to claim 1, wherein the foot-and-mouth disease type A Asian type is Sea-97 genotype. 제1항 또는 제3항에 있어서, 상기 재조합 바이러스는 구제역 백신용 바이러스인 것을 특징으로 하는 재조합 구제역 바이러스. The recombinant foot-and-mouth disease virus according to claim 1 or 3, wherein the recombinant virus is a foot-and-mouth disease vaccine virus. (1). 진뱅크 억세션 넘버 KC588943의 염기서열을 갖는 구제역 A형 한국 분리 바이러스의 전체 유전자를 플라스미드에 삽입하는 단계; 및
(2). 상기 (1) 단계에서 얻은 플라스미드를 세포에 주입하여 증식시키는 단계를 포함하는 재조합 구제역 바이러스의 제조방법.
(One). Inserting the whole gene of foot-and-mouth disease type A isolate virus having the nucleotide sequence of KC588943 in a plasmid; And
(2). And injecting the plasmid obtained in the step (1) into a cell to proliferate the recombinant FMDV.
제5항에 있어서, 상기 세포는 염소 태아 혀세포(ZZ-R), 돼지 신장 세포주(IBRS-2) 및 햄스터 세포주(BHK-21) 중에서 선택된 어느 하나 이상인 것을 특징으로 하는 재조합 구제역 바이러스의 제조방법.The recombinant foot-and-mouth disease virus according to claim 5, wherein the cell is at least one selected from the group consisting of fetal goat fetal tongue (ZZ-R), porcine kidney cell line (IBRS-2) and hamster cell line (BHK-21) . 제5항에 있어서, 상기 재조합 바이러스는 구제역 A형 아시아 지역형에 대한 방어 면역능을 갖는 것을 특징으로 하는 재조합 구제역 바이러스의 제조방법.6. The method according to claim 5, wherein the recombinant virus has defense immunity against the foot-and-mouth disease type A Asian region type. 제5항 내지 제7항 중 어느 한 항에 있어서, 상기 재조합 바이러스는 구제역 백신용 바이러스인 것을 특징으로 하는 재조합 구제역 바이러스의 제조방법.The method for producing recombinant foot-and-mouth disease virus according to any one of claims 5 to 7, wherein the recombinant virus is a foot-and-mouth disease vaccine virus. 제1항 또는 제3항의 재조합 구제역 바이러스를 포함하는 구제역 예방용 백신. A vaccine for the prevention of foot-and-mouth disease comprising the recombinant foot-and-mouth disease virus of claim 1 or 3.
KR1020130076352A 2013-07-01 2013-07-01 Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method KR101578444B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130076352A KR101578444B1 (en) 2013-07-01 2013-07-01 Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130076352A KR101578444B1 (en) 2013-07-01 2013-07-01 Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method

Publications (2)

Publication Number Publication Date
KR20150003947A KR20150003947A (en) 2015-01-12
KR101578444B1 true KR101578444B1 (en) 2015-12-21

Family

ID=52476344

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130076352A KR101578444B1 (en) 2013-07-01 2013-07-01 Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method

Country Status (1)

Country Link
KR (1) KR101578444B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132569A1 (en) * 2017-12-29 2019-07-04 (주)플럼라인생명과학 Vaccine composition for foot-and-mouth disease virus type a
KR20190082081A (en) * 2017-12-29 2019-07-09 (주)플럼라인생명과학 Vaccine composition for foot and mouth disease virus a serotype
RU2778095C2 (en) * 2017-12-29 2022-08-15 Пламблайн Лайф Сайенсиз, Инк. Vaccine composition against type a foot-and-mouth disease virus

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114423779A (en) * 2019-06-28 2022-04-29 株式会社准绳生命科学 Foot and mouth disease virus vaccine composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1632247A1 (en) * 2004-09-03 2006-03-08 Consejo Superior De Investigaciones Cientificas Nucleic acid sequences encoding FMDV proteins capable of associating into a virus-like particle

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jian-Zhong YI 등. Acta Biochimica et Biophysica Sinica. 2004, vol. 36, no. 9, pp. 589-596.*
NCBI GenBank: GQ406248.1, Foot-and-mouth disease virus - type A strain A/VN/02/2009 polyprotein gene, complete CDs, 2011.03.24.*

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132569A1 (en) * 2017-12-29 2019-07-04 (주)플럼라인생명과학 Vaccine composition for foot-and-mouth disease virus type a
KR20190082081A (en) * 2017-12-29 2019-07-09 (주)플럼라인생명과학 Vaccine composition for foot and mouth disease virus a serotype
KR102165358B1 (en) 2017-12-29 2020-10-14 (주)플럼라인생명과학 Vaccine composition for foot and mouth disease virus a serotype
RU2778095C2 (en) * 2017-12-29 2022-08-15 Пламблайн Лайф Сайенсиз, Инк. Vaccine composition against type a foot-and-mouth disease virus

Also Published As

Publication number Publication date
KR20150003947A (en) 2015-01-12

Similar Documents

Publication Publication Date Title
CN108753813B (en) Method for obtaining marker-free transgenic plants
CN107475267B (en) 4-hydroxyisoleucine production plasmid and strain and synthesis method of 4-hydroxyisoleucine
CN108486105B (en) Kluyveromyces marxianus promoter as well as preparation method and application thereof
CN110540989A (en) Primer and method for cloning unknown DNA sequence adjacent to known region based on PCR technology
CN111304252B (en) Method for injecting virus into specific brain region of animal for gene editing based on non-therapeutic purpose of PINK1 and PARK7
CN111171132B (en) Snakehead antibacterial peptide
KR101578444B1 (en) Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method
CN101775410B (en) Fowlpox virus vector shuttle plasmid and application thereof
CN101693901B (en) Colibacillus-corynebacterium inducible expression carrier pDXW-8 and building method thereof
CN113355296A (en) Recombinant oncolytic newcastle disease virus expressing human CCL19 and application thereof
KR101891603B1 (en) Recombinant foot-and-mouth disease virus expressing protective antigen of type A, Korean and standard strains
CN101343636A (en) Carrier of reverse gene system for construction of influenza virus and application thereof
CN111304257B (en) Method for gene editing by injecting virus into specific brain region of animal based on PSEN1 gene for non-therapeutic purpose
CN108728484B (en) Vector for obtaining marker-free transgenic plant and application thereof
CN102241763A (en) Continuously activated growth hormone receptor gene of fishes, and preparation method and application thereof
CN108410870B (en) Kluyveromyces marxianus promoter, secretion signal peptide, preparation and application thereof
KR101629345B1 (en) Foot and mouth disease virus expressing P1-protective antigen of Asia1 type, IV genotype and the manufacturing method
CN110157721A (en) A kind of tracer target practice plasmid of vaccinia virus Tiantan strain and preparation method thereof
CN109628416A (en) A kind of expression porcine circovirus 2 type ORF2 genetic recombination porcine pseudorabies virus strain and its construction method
CN109750005A (en) A kind of porcine pseudorabies recombinant virus and its construction method
CN113373163B (en) Codon-optimized Chlamydia trachomatis ctl0286 gene and application thereof
CN104450768B (en) A kind of shuttle vector for targeting yeast mitochondrial and its application
KR101629282B1 (en) Foot and mouth disease virus expressing P1-protective antigen of Asia1 type, V genotype and the manufacturing method
CN115109791B (en) Functional gene delivery vector based on IncQ plasmid flood host, construction method and application
US20100304461A1 (en) Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right